Literature DB >> 29976617

CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse.

Rocky L Baker1, Braxton L Jamison2, Timothy A Wiles2, Robin S Lindsay3, Gene Barbour2, Brenda Bradley2, Thomas Delong2, Rachel S Friedman3, Maki Nakayama4, Kathryn Haskins1.   

Abstract

We recently established that hybrid insulin peptides (HIPs), formed in islet β-cells by fusion of insulin C-peptide fragments to peptides of chromogranin A or islet amyloid polypeptide, are ligands for diabetogenic CD4 T-cell clones. The goal of this study was to investigate whether HIP-reactive T cells were indicative of ongoing autoimmunity. MHC class II tetramers were used to investigate the presence, phenotype, and function of HIP-reactive and insulin-reactive T cells in NOD mice. Insulin-reactive T cells encounter their antigen early in disease, but they express FoxP3 and therefore may contribute to immune regulation. In contrast, HIP-reactive T cells are proinflammatory and highly diabetogenic in an adoptive transfer model. Because the frequency of antigen-experienced HIP-reactive T cells increases over progression of disease, they may serve as biomarkers of autoimmune diabetes.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29976617      PMCID: PMC6110316          DOI: 10.2337/db18-0200

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.

Authors:  Frances Crawford; Brian Stadinski; Niyun Jin; Aaron Michels; Maki Nakayama; Philip Pratt; Philippa Marrack; George Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

2.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Authors:  Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John F Elliott; George S Eisenbarth
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

3.  Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.

Authors:  Maki Nakayama; Kristen McDaniel; Lisa Fitzgerald-Miller; Carol Kiekhaefer; Janet K Snell-Bergeon; Howard W Davidson; Marian Rewers; Liping Yu; Peter Gottlieb; John W Kappler; Aaron Michels
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

4.  An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse.

Authors:  Timothy A Wiles; Thomas Delong; Rocky L Baker; Brenda Bradley; Gene Barbour; Roger L Powell; Nichole Reisdorph; Kathryn Haskins
Journal:  J Autoimmun       Date:  2016-10-29       Impact factor: 7.094

5.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

6.  T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.

Authors:  Greig P Lennon; Maria Bettini; Amanda R Burton; Erica Vincent; Paula Y Arnold; Pere Santamaria; Dario A A Vignali
Journal:  Immunity       Date:  2009-10-08       Impact factor: 31.745

7.  Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.

Authors:  Rocky L Baker; Brenda Bradley; Timothy A Wiles; Robin S Lindsay; Gene Barbour; Thomas Delong; Rachel S Friedman; Kathryn Haskins
Journal:  J Immunol       Date:  2015-11-25       Impact factor: 5.422

8.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

9.  Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

Authors:  Brian T Fife; Indira Guleria; Melanie Gubbels Bupp; Todd N Eagar; Qizhi Tang; Helene Bour-Jordan; Hideo Yagita; Miyuki Azuma; Mohamed H Sayegh; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-11-20       Impact factor: 14.307

10.  Intraclonal competition limits the fate determination of regulatory T cells in the thymus.

Authors:  Jhoanne L Bautista; Chan-Wang J Lio; Stephanie K Lathrop; Katherine Forbush; Yuqiong Liang; Jingqin Luo; Alexander Y Rudensky; Chyi-Song Hsieh
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

View more
  34 in total

Review 1.  HIPs and HIP-reactive T cells.

Authors:  T A Wiles; T Delong
Journal:  Clin Exp Immunol       Date:  2019-06-17       Impact factor: 4.330

2.  T-cell responses to hybrid insulin peptides prior to type 1 diabetes development.

Authors:  Angela M Mitchell; Aimon A Alkanani; Kristen A McDaniel; Laura Pyle; Kathleen Waugh; Andrea K Steck; Maki Nakayama; Liping Yu; Peter A Gottlieb; Marian J Rewers; Aaron W Michels
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

Review 3.  Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes.

Authors:  Stuart I Mannering; Anthony R Di Carluccio; Colleen M Elso
Journal:  Diabetologia       Date:  2018-11-06       Impact factor: 10.122

4.  Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells.

Authors:  Braxton L Jamison; Tobias Neef; Andrew Goodspeed; Brenda Bradley; Rocky L Baker; Stephen D Miller; Kathryn Haskins
Journal:  J Immunol       Date:  2019-05-20       Impact factor: 5.422

Review 5.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

6.  Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetes.

Authors:  Rocky L Baker; Braxton L Jamison; Kathryn Haskins
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-08       Impact factor: 3.243

7.  A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery.

Authors:  Baoyu Liu; Jennifer D Hood; Elizabeth M Kolawole; Derek M Woodruff; Dario A Vignali; Maria Bettini; Brian D Evavold
Journal:  Diabetes       Date:  2019-12-05       Impact factor: 9.461

8.  Engineering immunomodulatory biomaterials for type 1 diabetes.

Authors:  C L Stabler; Y Li; J M Stewart; B G Keselowsky
Journal:  Nat Rev Mater       Date:  2019-05-17       Impact factor: 66.308

9.  Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor.

Authors:  Gisela M Vaitaitis; Marynette Rihanek; Aimon K Alkanani; Dan M Waid; Peter A Gottlieb; David H Wagner
Journal:  J Clin Endocrinol Metab       Date:  2019-05-07       Impact factor: 5.958

Review 10.  Peptide mimotopes alter T cell function in cancer and autoimmunity.

Authors:  Jill E Slansky; Maki Nakayama
Journal:  Semin Immunol       Date:  2020-03-20       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.